Security key
62818Q203
Mustang Bio, Inc. - Common Stock, $0.0001 Par Value (MBIO)
CUSIP: 62818Q203
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, $0.0001 Par Value
- Total 13F shares
- 879,309
- Total 13F value
- $207,208
- Share change
- +97,195
- SEC-reported price per share
- $0.24
- Number of holders
- 24
- Value change
- -$5,892
- Number of buys
- 8
- Number of sells
- 10
- Shares outstanding
- 52,979,435
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
24
Top holders
10
MBIO full security history
Ownership snapshot
Full 13F holder table
MUSTANG BIO, INC. SEC filings
MUSTANG BIO, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of MBIO - Mustang Bio, Inc. - Common Stock, $0.0001 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
UBS Group AG
Disclosed value leader
UBS Group AG
Comparable rows
0/15
Latest evidence
30 Jun 2024
13F
3/4/5
Highest disclosed value: $91,561
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
UBS Group AG has the largest disclosed position value at $91.6K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens UBS Group AG's linked filing trail.
Disclosed position value
Top 5
UBS Group AG
$91.6K
Brian Achenbach
$74.7K
Koss-Olinger Consulting, LLC
$47K
BlackRock Finance, Inc.
$41.3K
VANGUARD GROUP INC
$35.7K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$91,561
193,575 shares
|
— | 30 Jun 2024 |
| Brian Achenbach |
3/4/5
SVP, Fin. & Corp. Controller
|
—
denominator unverified
|
$74,738
144,729 shares
|
— | 08 Dec 2021 |
| Koss-Olinger Consulting, LLC |
13F
Company
|
—
denominator unverified
|
$47,000
98,366 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$41,253
87,216 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$35,661
75,394 shares
|
— | 30 Jun 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$35,372
74,772 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
24
Shares
879,309
Rows available
24
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
27
Q3 2024 holders
24
Holder diff
-3
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|